Yüklüyor......
Thioredoxin decreases anthracycline cardiotoxicity, but sensitizes cancer cell apoptosis
Cardiotoxicity is a major limitation for anthracycline chemotherapy although anthracyclines are potent antitumor agents. The precise mechanism underlying clinical heart failure due to anthracycline treatment is not fully understood, but is believed to be due, in part, to lipid peroxidation and the g...
Kaydedildi:
| Yayımlandı: | Cardiovasc Toxicol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854973/ https://ncbi.nlm.nih.gov/pubmed/32880787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12012-020-09605-2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|